1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Conjunctivitis Consumption Value by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Antibiotic
  • 1.3.3 Pills
  • 1.3.4 Ointment
• 1.4 Market Analysis by End User
  • 1.4.1 Overview: Global Conjunctivitis Consumption Value by End User: 2020 Versus 2024 Versus 2031
  • 1.4.2 Newborns
  • 1.4.3 Children
  • 1.4.4 Adults
• 1.5 Global Conjunctivitis Market Size & Forecast
  • 1.5.1 Global Conjunctivitis Consumption Value (2020 & 2024 & 2031)
  • 1.5.2 Global Conjunctivitis Sales Quantity (2020-2031)
  • 1.5.3 Global Conjunctivitis Average Price (2020-2031)

2 Manufacturers Profiles

• 2.1 Novartis (CH)
  • 2.1.1 Novartis (CH) Details
  • 2.1.2 Novartis (CH) Major Business
  • 2.1.3 Novartis (CH) Conjunctivitis Product and Services
  • 2.1.4 Novartis (CH) Conjunctivitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Novartis (CH) Recent Developments/Updates
• 2.2 Santen Pharmaceutical (JP)
  • 2.2.1 Santen Pharmaceutical (JP) Details
  • 2.2.2 Santen Pharmaceutical (JP) Major Business
  • 2.2.3 Santen Pharmaceutical (JP) Conjunctivitis Product and Services
  • 2.2.4 Santen Pharmaceutical (JP) Conjunctivitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Santen Pharmaceutical (JP) Recent Developments/Updates
• 2.3 Bausch & Lomb (US)
  • 2.3.1 Bausch & Lomb (US) Details
  • 2.3.2 Bausch & Lomb (US) Major Business
  • 2.3.3 Bausch & Lomb (US) Conjunctivitis Product and Services
  • 2.3.4 Bausch & Lomb (US) Conjunctivitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Bausch & Lomb (US) Recent Developments/Updates
• 2.4 Allergan (US)
  • 2.4.1 Allergan (US) Details
  • 2.4.2 Allergan (US) Major Business
  • 2.4.3 Allergan (US) Conjunctivitis Product and Services
  • 2.4.4 Allergan (US) Conjunctivitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Allergan (US) Recent Developments/Updates
• 2.5 Sun Pharmaceutical (ID)
  • 2.5.1 Sun Pharmaceutical (ID) Details
  • 2.5.2 Sun Pharmaceutical (ID) Major Business
  • 2.5.3 Sun Pharmaceutical (ID) Conjunctivitis Product and Services
  • 2.5.4 Sun Pharmaceutical (ID) Conjunctivitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 Sun Pharmaceutical (ID) Recent Developments/Updates
• 2.6 Akorn (US)
  • 2.6.1 Akorn (US) Details
  • 2.6.2 Akorn (US) Major Business
  • 2.6.3 Akorn (US) Conjunctivitis Product and Services
  • 2.6.4 Akorn (US) Conjunctivitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Akorn (US) Recent Developments/Updates
• 2.7 Freda (CN)
  • 2.7.1 Freda (CN) Details
  • 2.7.2 Freda (CN) Major Business
  • 2.7.3 Freda (CN) Conjunctivitis Product and Services
  • 2.7.4 Freda (CN) Conjunctivitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Freda (CN) Recent Developments/Updates
• 2.8 Sinqi (CN)
  • 2.8.1 Sinqi (CN) Details
  • 2.8.2 Sinqi (CN) Major Business
  • 2.8.3 Sinqi (CN) Conjunctivitis Product and Services
  • 2.8.4 Sinqi (CN) Conjunctivitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 Sinqi (CN) Recent Developments/Updates
• 2.9 Univision (CN)
  • 2.9.1 Univision (CN) Details
  • 2.9.2 Univision (CN) Major Business
  • 2.9.3 Univision (CN) Conjunctivitis Product and Services
  • 2.9.4 Univision (CN) Conjunctivitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 Univision (CN) Recent Developments/Updates

3 Competitive Environment: Conjunctivitis by Manufacturer

• 3.1 Global Conjunctivitis Sales Quantity by Manufacturer (2020-2025)
• 3.2 Global Conjunctivitis Revenue by Manufacturer (2020-2025)
• 3.3 Global Conjunctivitis Average Price by Manufacturer (2020-2025)
• 3.4 Market Share Analysis (2024)
  • 3.4.1 Producer Shipments of Conjunctivitis by Manufacturer Revenue ($MM) and Market Share (%): 2024
  • 3.4.2 Top 3 Conjunctivitis Manufacturer Market Share in 2024
  • 3.4.3 Top 6 Conjunctivitis Manufacturer Market Share in 2024
• 3.5 Conjunctivitis Market: Overall Company Footprint Analysis
  • 3.5.1 Conjunctivitis Market: Region Footprint
  • 3.5.2 Conjunctivitis Market: Company Product Type Footprint
  • 3.5.3 Conjunctivitis Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Conjunctivitis Market Size by Region
  • 4.1.1 Global Conjunctivitis Sales Quantity by Region (2020-2031)
  • 4.1.2 Global Conjunctivitis Consumption Value by Region (2020-2031)
  • 4.1.3 Global Conjunctivitis Average Price by Region (2020-2031)
• 4.2 North America Conjunctivitis Consumption Value (2020-2031)
• 4.3 Europe Conjunctivitis Consumption Value (2020-2031)
• 4.4 Asia-Pacific Conjunctivitis Consumption Value (2020-2031)
• 4.5 South America Conjunctivitis Consumption Value (2020-2031)
• 4.6 Middle East & Africa Conjunctivitis Consumption Value (2020-2031)

5 Market Segment by Type

• 5.1 Global Conjunctivitis Sales Quantity by Type (2020-2031)
• 5.2 Global Conjunctivitis Consumption Value by Type (2020-2031)
• 5.3 Global Conjunctivitis Average Price by Type (2020-2031)

6 Market Segment by End User

• 6.1 Global Conjunctivitis Sales Quantity by End User (2020-2031)
• 6.2 Global Conjunctivitis Consumption Value by End User (2020-2031)
• 6.3 Global Conjunctivitis Average Price by End User (2020-2031)

7 North America

• 7.1 North America Conjunctivitis Sales Quantity by Type (2020-2031)
• 7.2 North America Conjunctivitis Sales Quantity by End User (2020-2031)
• 7.3 North America Conjunctivitis Market Size by Country
  • 7.3.1 North America Conjunctivitis Sales Quantity by Country (2020-2031)
  • 7.3.2 North America Conjunctivitis Consumption Value by Country (2020-2031)
  • 7.3.3 United States Market Size and Forecast (2020-2031)
  • 7.3.4 Canada Market Size and Forecast (2020-2031)
  • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

• 8.1 Europe Conjunctivitis Sales Quantity by Type (2020-2031)
• 8.2 Europe Conjunctivitis Sales Quantity by End User (2020-2031)
• 8.3 Europe Conjunctivitis Market Size by Country
  • 8.3.1 Europe Conjunctivitis Sales Quantity by Country (2020-2031)
  • 8.3.2 Europe Conjunctivitis Consumption Value by Country (2020-2031)
  • 8.3.3 Germany Market Size and Forecast (2020-2031)
  • 8.3.4 France Market Size and Forecast (2020-2031)
  • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
  • 8.3.6 Russia Market Size and Forecast (2020-2031)
  • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

• 9.1 Asia-Pacific Conjunctivitis Sales Quantity by Type (2020-2031)
• 9.2 Asia-Pacific Conjunctivitis Sales Quantity by End User (2020-2031)
• 9.3 Asia-Pacific Conjunctivitis Market Size by Region
  • 9.3.1 Asia-Pacific Conjunctivitis Sales Quantity by Region (2020-2031)
  • 9.3.2 Asia-Pacific Conjunctivitis Consumption Value by Region (2020-2031)
  • 9.3.3 China Market Size and Forecast (2020-2031)
  • 9.3.4 Japan Market Size and Forecast (2020-2031)
  • 9.3.5 South Korea Market Size and Forecast (2020-2031)
  • 9.3.6 India Market Size and Forecast (2020-2031)
  • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
  • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

• 10.1 South America Conjunctivitis Sales Quantity by Type (2020-2031)
• 10.2 South America Conjunctivitis Sales Quantity by End User (2020-2031)
• 10.3 South America Conjunctivitis Market Size by Country
  • 10.3.1 South America Conjunctivitis Sales Quantity by Country (2020-2031)
  • 10.3.2 South America Conjunctivitis Consumption Value by Country (2020-2031)
  • 10.3.3 Brazil Market Size and Forecast (2020-2031)
  • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

• 11.1 Middle East & Africa Conjunctivitis Sales Quantity by Type (2020-2031)
• 11.2 Middle East & Africa Conjunctivitis Sales Quantity by End User (2020-2031)
• 11.3 Middle East & Africa Conjunctivitis Market Size by Country
  • 11.3.1 Middle East & Africa Conjunctivitis Sales Quantity by Country (2020-2031)
  • 11.3.2 Middle East & Africa Conjunctivitis Consumption Value by Country (2020-2031)
  • 11.3.3 Turkey Market Size and Forecast (2020-2031)
  • 11.3.4 Egypt Market Size and Forecast (2020-2031)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
  • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

• 12.1 Conjunctivitis Market Drivers
• 12.2 Conjunctivitis Market Restraints
• 12.3 Conjunctivitis Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Conjunctivitis and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Conjunctivitis
• 13.3 Conjunctivitis Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Conjunctivitis Typical Distributors
• 14.3 Conjunctivitis Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Conjunctivitis market size was valued at US$ 3780 million in 2024 and is forecast to a readjusted size of USD 4209 million by 2031 with a CAGR of 1.6% during review period.
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected.
The technical barriers of conjunctivitis industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Novartis, Santen Pharmaceutical, Bausch + Lomb, Allergan, Sun Pharmaceutical, Akorn and Sinqi, etc.
This report is a detailed and comprehensive analysis for global Conjunctivitis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Conjunctivitis market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Conjunctivitis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Conjunctivitis market size and forecasts, by Type and by End User, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Conjunctivitis market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Conjunctivitis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Conjunctivitis market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis (CH), Santen Pharmaceutical (JP), Bausch & Lomb (US), Allergan (US), Sun Pharmaceutical (ID), Akorn (US), Freda (CN), Sinqi (CN), Univision (CN), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Conjunctivitis market is split by Type and by End User. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antibiotic
Pills
Ointment
Market segment by End User
Newborns
Children
Adults
Major players covered
Novartis (CH)
Santen Pharmaceutical (JP)
Bausch & Lomb (US)
Allergan (US)
Sun Pharmaceutical (ID)
Akorn (US)
Freda (CN)
Sinqi (CN)
Univision (CN)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Conjunctivitis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Conjunctivitis, with price, sales quantity, revenue, and global market share of Conjunctivitis from 2020 to 2025.
Chapter 3, the Conjunctivitis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Conjunctivitis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by End User, with sales market share and growth rate by Type, by End User, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Conjunctivitis market forecast, by regions, by Type, and by End User, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Conjunctivitis.
Chapter 14 and 15, to describe Conjunctivitis sales channel, distributors, customers, research findings and conclusion.